16:09 EDT CytomX Therapeutics files $250M mixed securities shelf
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTMX:
- CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
- CTMX Earnings this Week: How Will it Perform?
- CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
- CytomX Therapeutics Appoints Chris Ogden as New CFO
- CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer